Suppr超能文献

Which population groups should be targeted for cardiovascular prevention? A modelling study based on the Norwegian Hordaland Health Study (HUSK).

作者信息

Brekke Mette, Rekdal Magne, Straand Jørund

机构信息

Section for General Practice, Department of General Practice and Community Health, University of Oslo, Norway.

出版信息

Scand J Prim Health Care. 2007 Jun;25(2):105-11. doi: 10.1080/02813430701241087.

Abstract

OBJECTIVE

To assess level of cardiovascular risk factors in a non-selected, middle-aged population. To estimate the proportion target for risk intervention according to present guidelines and according to different cut-off levels for two risk algorithms.

DESIGN

Population survey, modelling study.

SETTING

The Norwegian Hordaland Health Study (HUSK) 1997-99.

SUBJECTS

A total of 22 289 persons born in 1950-57.

MAIN OUTCOME MEASURES

Own and relatives' cardiovascular morbidity, antihypertensive and lipid-lowering treatment, smoking, blood pressure, cholesterol. Framingham and Systematic Coronary Risk Evaluation (SCORE) algorithms. The European guidelines on CVD prevention in clinical practice were applied to estimate size of risk groups.

RESULTS

Some 9.7% of men and 7.6% of women had CVD, diabetes mellitus, a high level of one specific risk factor, or received lipid-lowering or antihypertensive treatment. Applying a SCORE (60 years) cut-off level at 5% to the rest of the population selected 52.4% of men and 0.8% of women into a primary prevention group, while a cut-off level at 8% included 22.0% and 0.06% respectively. A cut-off level for the Framingham score (60 years) of 20% selected 43.6% of men and 4.7% of women, while a cut-off level of 25% selected 25.6% of men and 1.8% of women.

CONCLUSION

The findings illustrate how choices regarding risk estimation highly affect the size of the target population. Modelling studies are important when preparing guidelines, to address implications for resource allocation and risk of medicalization. The population share to be targeted for primary prevention ought to be estimated, including the impact of various cut-off points for risk algorithms on the size of the risk population.

摘要

相似文献

4
Aspirin for primary prevention: yes or no?
J Prim Health Care. 2010 Jun;2(2):92-9.
9
Trends in cardiovascular risk factors among U.S. men and women with and without diabetes, 1988-2014.
BMC Public Health. 2017 Nov 22;17(1):893. doi: 10.1186/s12889-017-4921-4.
10
Underutilisation of cardiovascular medications among at-risk individuals.
Int J Clin Pract. 2010 Apr;64(5):604-10. doi: 10.1111/j.1742-1241.2009.02258.x. Epub 2009 Nov 11.

本文引用的文献

1
Predicting cardiovascular risk: so what do we do now?
Arch Intern Med. 2006 Jul 10;166(13):1342-4. doi: 10.1001/archinte.166.13.1342.
3
Why do sales of lipid-lowering drugs vary between counties in Norway? Evidence from the OPPHED Health Study 2000-2001.
Scand J Prim Health Care. 2006 Jun;24(2):115-21. doi: 10.1080/02813430500475365.
4
Revisiting Rose: strategies for reducing coronary heart disease.
BMJ. 2006 Mar 18;332(7542):659-62. doi: 10.1136/bmj.332.7542.659.
5
Preventing coronary heart disease.
BMJ. 2006 Mar 18;332(7542):617-8. doi: 10.1136/bmj.332.7542.617.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验